eBay
EBAY
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
Workday
WDAY
US Stock MarketDetailed Quotes
ARGX argenx SE
- 661.200
- +12.580+1.94%
Trading Jan 8 09:49 ET
39.54BMarket Cap-847.69P/E (TTM)
662.810High658.130Low49.03KVolume658.130Open648.620Pre Close32.41MTurnover0.08%Turnover RatioLossP/E (Static)59.80MShares662.81052wk High9.28P/B39.51BFloat Cap349.86052wk Low--Dividend TTM59.76MShs Float662.810Historical High--Div YieldTTM0.72%Amplitude17.330Historical Low660.979Avg Price1Lot Size
About argenx SE Company
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
Company Profile
SymbolARGX
Company Nameargenx SE
Listing DateMay 18, 2017
Issue Price17.00
Founded2008
CEOMr. Tim Van Hauwermeiren, M. Sc.
MarketNASDAQ
Employees1148
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressLaarderhoogtweg 25
CityAmsterdam
ProvinceNoord-Holland
CountryNetherlands (the)
Zip Code1101 EB
Phone31-76-303-04-88
Websitehttp://www.argen-x.com
Company Executives
- Name
- Position
- Salary
- Tim Van Hauwermeiren, M. Sc.
- Executive Director and Chief Executive Officer
- 17.45M
- Karen Massey
- Chief Operating Officer
- 7.32M
- Dr. Luc Truyen, M.D.,PhD
- Chief Medical Officer
- --
- Dr. Peter Ulrichts
- Chief Scientific Officer
- --
- Karl Gubitz
- Chief Financial Officer
- 4.76M
- Arjen Lemmen
- Vice President, Corporate Development and Strategy
- --
- Peter K.M. Verhaeghe
- Non-Executive Chairman of the Board
- 660.33K
- Anthony A. Rosenberg
- Independent Director
- 476.82K
- Dr. Ana Cespedes, PhD
- Independent Director
- 261.39K
- James M. Daly
- Independent Director
- 482.23K
- Dr. J. Donald deBethizy, PhD
- Independent Director
- 482.23K
- Camilla Sylvest
- Independent Director
- 365.24K
- Dr. Pamela M. Klein, M.D.
- Independent Director
- 471.41K
- Steven E. Krognes
- Independent Director
- 635.65K
- Malini Moorthy
- General Counsel
- --
- Andria Wilk
- Global Head, Quality
- --